EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 2 June 2022

From Crisis to Catalyst: What role for the Pharmaceutical industry in Europe

Nathalie Moll for PharmaBoardroom

Nathalie Moll shares her views on the pharma industry’s response to COVID-19 and Europe’s preparedness for future health crises. She also discusses the reach and ambition of the Pharma Strategy and addresses the issues around equitable access.

"The pandemic was an intense microcosm of some of our wider healthcare challenges and focused attention on areas that can be improved. There is a need to look for longer-term health outcomes, focus on early care prevention, digitalization, telemedicine and new payment models."

Read more

Blogs

Is health truly a European value?
02 June 2022 - Ivana Cattaneo

The pandemic has shown us how much we can achieve when there is political will. We can act together, efficiently and... Read more

Are You Fair When Designing Your Oncology Trials?
01 June 2022 - Solange Corriol-Rohou

There should be no more missed opportunities for adolescent patients with cancer! Read more

Getting the world vaccinated against COVID-19 (1)
01 June 2022

The latest data on the situation regarding production of COVID-19 vaccines and vaccination rates show that production... Read more

Events

IHI Kick-off and brokerage event
14 June 2022 (Hotel Le Plaza Brussels & virtual)

Save the date for the first IHI brokerage event Read more

The Women’s Brain Project webinar series
20 June 2022 (Virtual event)

Registrations are open! Read more

EPF Congress 2022 – Continuing the conversation on digital transformation
23 June 2022 (DoubleTree by Hilton, Brussels & Online)

You are invited. Read more

From Crisis to Catalyst: Build resilience, back innovation and boost access
29 June 2022 (Concert Noble, Brussels, & Online)

You are invited to EFPIA 2022 Conference. Read more

World Environment Day

Join us in raising awareness on how to safely dispose of unused or expired medicines in Europe. Check the MedsDisposal website to discover more: http://medsdisposal.eu/get-involved/

What we are reading

Czech experts: Tackling cancer care inequalities in Europe requires more data
On 25 May 2022 (Euractiv)

According to the EFPIA WAIT Indicator, the country ranks 14th in the EU in the availability of new oncology drugs, along... Read more

Gene therapy offers new hope for stroke and MS patients
On 27 May 2022 (The Times)

Treatment to reduce brain inflammation shows ‘exciting’ results in mice. Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu